This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!
Drug Safety - First 'Type A' Accreditation for Independent API Inspections Awarded
NewswireToday - /newswire/ -
Muenster, North Rhine-Westfalia, Germany, 06/10/2008 - As the first API auditor in Europe, blue inspection body GmbH has been accredited to carry out inspections of active pharmaceutical ingredient manufacturers and has been awarded the highest independence rating, type "A".
The blue inspection body GmbH is the first inspection body for active pharmaceutical ingredients (API) in the European Union to be accredited with the highest level of independence, type A. The audit service provider operates worldwide on behalf of pharmaceutical companies to check whether API suppliers meet the requirements of Good Manufacturing Practice. Audits are considered an important means of improving the safety of medicinal products. Since 2006 they have been required for active pharmaceutical ingredients manufactured in other countries to be allowed to undergo further processing in Europe. It is estimated that almost 80% of all starting materials and excipients for medicinal products in the EU and the USA come from third countries.
blue inspection has been accredited by the DAP German Accreditation System for Testing in accordance with the international standard ISO/IEC 17020. The type A accreditation it has been awarded certifies that the company is a qualified and competent auditor – and that it is independent from the medicinal product manufacturer in Europe as well as from the API supplier that is to be inspected in, for example, India or China.
The importance of plant inspections for the safety of medicinal products is illustrated by the heparin scare in early 2008: at that time a Chinese active pharmaceutical ingredient supplier had supplied contaminated batches of heparin to medicinal product manufacturers worldwide. The result was more than 80 deaths in the USA alone. During investigations it emerged that the US medicinal products agency, the FDA, had not inspected the company as required because of a staff shortage. In Europe, the manufacturers of medicinal products are directly responsible for inspections of suppliers. For these they use, among others, specialized audit service providers such as blue inspection body GmbH.
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
Distribution: [+] Free Press Release & Newswire Distribution Network. via PRZOOM - Newswire Today (NewswireToday.com)
# # #
Your Banner Ad showing on ALL Pharma/BioTech/Nutrition articles, CATCH Visitors via Your Competitors Announcements! Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
Contact: Dr. Stefan Kettelhoit
+49 251 625620-40 stefan.kettelhoit[.]blue-inspection.com
Newswire Today - PRZOOM disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.